Compare SVRA & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRA | HIVE |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | SVRA | HIVE |
|---|---|---|
| Price | $5.83 | $3.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $6.88 | ★ $8.33 |
| AVG Volume (30 Days) | 2.2M | ★ 20.7M |
| Earning Date | 11-12-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $193,254,000.00 |
| Revenue This Year | N/A | $192.81 |
| Revenue Next Year | N/A | $40.30 |
| P/E Ratio | ★ N/A | $16.01 |
| Revenue Growth | N/A | ★ 57.09 |
| 52 Week Low | $1.89 | $1.26 |
| 52 Week High | $6.37 | $7.84 |
| Indicator | SVRA | HIVE |
|---|---|---|
| Relative Strength Index (RSI) | 74.17 | 36.32 |
| Support Level | $5.09 | $2.95 |
| Resistance Level | $6.37 | $3.56 |
| Average True Range (ATR) | 0.39 | 0.34 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 82.26 | 22.52 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.